Page last updated: 2024-08-26

arsenic and Hepatocellular Carcinoma

arsenic has been researched along with Hepatocellular Carcinoma in 130 studies

Research

Studies (130)

TimeframeStudies, this research(%)All Research%
pre-19907 (5.38)18.7374
1990's3 (2.31)18.2507
2000's48 (36.92)29.6817
2010's60 (46.15)24.3611
2020's12 (9.23)2.80

Authors

AuthorsStudies
Ali, M; Bhardwaj, SK; Chaudhary, A; Haque, R; Khan, A; Sinha, KK; Srivastava, A1
Cheng, M; Li, B; Li, F; Piao, JG; Sun, J; Wei, Y; Ye, T; Zheng, H; Zhou, M1
Aki, T; Funakoshi, T; Kukita, M; Takata, M; Uemura, K; Unuma, K1
Gu, SY; Li, Y; Zhang, ZZ1
Fang, L; Huang, P; Islam, K; Liu, YJ; Naranmandura, H; Wang, C; Yang, C; Zhang, H; Zhang, YH; Zhang, YW; Zheng, XW1
Du, P; Lu, W; Yang, C; Zhang, JC; Zhang, JL1
Chen, CF; Chern, CL; Ho, CT; Lin, LC; Liu, JJ; Liu, TZ1
Hai, Y; Li, H; Li, Y; Ma, W; Song, P; Wang, X; Wu, Z; Xie, Q; Zhao, L1
Ali, M; Ali, V; Bimal, S; Haque, R; Kumar, N; Sadaf, N1
Ji, S; Li, W; Wang, L; Wang, M; Zhang, C; Zhang, J1
Ao, JY; Bu, Y; Chai, ZT; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Zhang, KZ; Zhang, QB; Zhang, YY; Zhu, XD1
Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X1
Fang, ZT; Li, S; Liu, R; Qian, S; Qu, XD; Wang, GZ; Wang, JH; Wang, LL; Yang, GW; Yang, MJ; Zhang, W; Zhang, WS; Zhu, L1
Fan, Z; Huaqun, F; Kai, W; Kaiyang, W; Linquan, W; Mingwen, H; Xiangbao, Y; Xin, Y1
Chen, X; Jiang, H; Li, Y; Liang, Y; Liu, J; Liu, L; Lu, Z; Meng, X; Pan, S; Qi, S; Song, X; Sun, B; Wang, J; Xie, C; Yin, D; Zheng, T1
Liu, F; Wang, W; Wei, J; Ye, C1
Jiang, F; Li, Y; Li, Z; Liu, Q; Shen, J; Wang, X; Zhang, J1
Jiang, F; Li, Y; Li, Z; Liu, Q; Lu, X; Shen, J; Wang, X; Zhang, J1
Chen, CZ; Hu, YN; Jiang, XJ; Zhang, ZZ; Zhao, W1
He, C; Jiang, H; Jiang, X; Ma, L; Sun, X; Xu, L; Zhai, B; Zhao, D1
Ling, S; Sun, D; Tian, Y; Wang, L; Yang, X1
Deng, J; Li, Y; Luo, Q; Zhang, Z1
He, X; Hu, BS; Huang, JW; Li, Y; Liu, B; Lu, LG; Zhao, W; Zheng, YB1
Deng, JJ; Li, Y; Luo, QY; Zhang, ZZ1
Lai, Y; Li, Y; Luo, Q; Zhang, Z1
Jin, G; Liu, D; Liu, Y; Sun, Z; Wang, C; Wang, H; Wang, X; Yu, S; Zhang, B1
Cao, Y; Fan, J; He, YF; Hu, B; Huang, XW; Qiu, SJ; Sun, C; Sun, YF; Wang, Z; Yang, XR; Zeng, HY; Zhang, X; Zhou, J1
Cao, Z; Chen, X; Cui, L; Gao, B; Zhang, S; Zhang, W1
Chi, X; Gao, J; Liu, H; Shan, H; Zhang, Z; Zhao, Z; Zhou, H; Zhu, X1
Chen, C; Hu, H; Li, H1
Gu, SY; Hu, YN; Zhang, ZZ1
Chen, M; Cheng, X; Fan, X; Ji, J; Song, J; Wu, F; Ying, X; Zhang, D; Zhao, Z1
Chang, Y; Jiang, M; Zhou, Q; Zhou, R; Zhu, C1
Cheng, L; Cheng, P; Huang, A; Liao, D; Ma, J; Tong, A; Wei, Y; Yue, D1
Fan, L; Liang, K; Liang, W; Peng, G; Wang, L; Wang, R; Xu, Y; Ye, Q1
Chen, P; Cui, P; Duan, Z; Gao, Q; Li, H; Li, Y; Song, P; Wang, A; Wang, D; Wang, X; Wang, Y; Wu, Z; Zhao, L; Zhu, R; Zhu, S1
Fei, W; Han, S; Li, F; Tao, J; Wang, X; Wei, Y; Zhang, Y; Zheng, H; Zhu, J1
Gao, F; Liu, Y; Song, W1
Lv, XH; Wang, CH; Xie, Y1
Cheng, C; Cui, X; Fei, M; Gao, S; He, S; Ke, Q; Li, P; Liu, Y; Lu, M; Shen, A; Wang, Y; Zhao, Y1
Cao, EH; Liang, XQ; Liu, XM; Song, Y; Tang, RJ; Xiong, XF1
Kita, K; Ochi, T; Sato, M; Suzuki, T1
Abbadessa, G; Blaszkowsky, LS; Chen, H; Costa, M; Feun, L; Gold, P; Henderson, C; Hochster, H; Lewis, J; Muggia, F; Nierodzik, M; Rosenzweig, B; Ryan, T; Van Veldhuizen, P; Wu, J; Zheng, H; Zhu, AX1
Jiang, HC; Liu, TF; Song, PL; Sun, B; Zhao, XS1
Chen, X; Jiang, H; Krissansen, GW; Ma, Y; Pan, S; Sun, B; Sun, X1
Chen, X; Jiang, H; Liu, L; Ma, Y; Pan, S; Sun, X; Wang, J; Zhu, H1
Chen, X; Jiang, HC; Liu, LX; Meng, XZ; Pan, SH; Wang, JB; Zhang, WH; Zheng, TS1
Chang, YJ; Cheng, YW; Chiou, JF; Hsieh, PY; Hsu, CH; Ko, HL; Liu, TZ; Ting, LL; Tung, JN; Wu, AT1
Han, H; Jiang, T; Lu, H; Luo, R; Shen, P1
Chen, BA; Liu, L; Qin, SK1
Chen, C; Huang, D; Qi, Y; Wang, Y; Xi, Y; Zhang, Y1
Hua, H; Li, J; Qin, S; Rui, J1
Hong, DY; Huang, HS; Liu, ZM; Tseng, JT1
Acalovschi, M; Aldea, M; Fischer-Fodor, E; Irimie, A; Kacso, G; Mosteanu, O; Petrushev, B; Pop, T; Soritau, O; Susman, S; Tomuleasa, C1
Bian, J; Guo, J; Wang, Y; Wu, H; Wu, X; Zhang, C; Zhang, S; Zhou, J1
Chen, G; Chen, JX; Hua, ZC; Tang, B; Wang, K; Yang, BY1
Chen, Q; Hao, XZ; Liu, JW; Qin, SK; Qu, FL; Qu, T; Sui, GJ; Sun, Y; Zhang, HP1
Diwan, BA; Thomas, DJ; Tokar, EJ; Waalkes, MP1
Jia, S; Yang, S; Yang, T; Yang, Y; Zhang, X1
Allensworth, JL; Devi, GR; Diehl, AM; Lyerly, HK; Morse, MA; Rangwala, F; Smith, GR; Thomas, Z; Williams, KP1
Cao, LM; Li, HY1
Cheng, HT; Guo, CY; Hu, HT; Li, HL; Luo, JP; Meng, YL; Xiao, JC; Yao, QJ1
Chen, CX; Huang, FL; Wang, HN; Wang, YL1
Allain, N; Fardel, O; Guillouzo, A; Le Vée, M; Morel, F; Vernhet, L1
Liu, JW; Shen, Y; Tang, Y; Zhong, XY1
Chen, GQ; Chen, Z; Jing, Y; Styblo, M; Walton, F; Waxman, S; Weinberg, R; Zhou, L1
Hong, L; Qi, QH; Wang, SS; Wang, XL; Zhang, T1
Akao, Y; Futatsugawa, S; Kito, M; Matsumoto, K; Naoe, T; Nozawa, Y; Sera, K; Wada, N1
Li, JT; Ou, QJ; Wu, YC1
Bi, L; Chen, SX; Liu, SM; Xu, HY; Yang, YL1
Chen, H; Hua, HQ; Qin, SK; Wang, JH1
Chen, W; Guo, HX; Jiang, HC; Liu, LX; Liu, ZH; Wang, XQ; Wu, M; Zhang, TD; Zhu, AL1
Dopp, E; Florea, AM; Hartmann, LM; Hirner, AV; Rabieh, S; Rettenmeier, AW; Shokouhi, B; von Recklinghausen, U; Yadav, S; Zimmermann, U1
Chan, JY; Fung, KP; Siu, KP2
Dong, X; Jiang, H; Kanwar, JR; Krissansen, GW; Luo, L; Meng, F; Qiao, H; Sun, X; Zhou, B1
Li, BX; Lin, DH; Lin, LM; Xiao, JB; Yang, BF1
Kaise, T; Kinoshita, K; Miyazaki, K; Noguchi, A; Ochi, T; Suzuki, T1
Cui, X; Hatakeyama, K; Hirano, S; Shirai, Y; Wakai, T; Yokoyama, N1
Kaise, T; Kinoshita, K; Kita, K; Ochi, T; Suzuki, T1
Fu, Q; Hu, BR; Li, JJ; Li, Y; Ming, ZY; Qian, JQ; Tang, Q; Xiang, JZ1
Cheng, AL; Hsu, C; Hsu, CH; Hsu, WL; Lin, CC; Yang, CH1
Kita, K; Ochi, T; Suzuki, T1
Kumar, R; Mukhopadhyay, AK; Paul, MK1
Cui, XP; Li, P; Lu, MD; Shen, AG; Wang, Y1
Chen, Q; Gao, P; Jin, H; Tian, C; Wang, X; Yue, W; Zheng, Y1
Cui, YZ; Luo, RC; Wu, J; Zhang, H1
Pasco, DS; Siu, CS; Xu, C1
Chen, H; Liu, L; Liu, W; Ma, J; Qin, S; Wang, J1
Lewitt, MS1
Chen, BA; Chen, HY; Qin, SK; Wang, W1
Akao, Y; Kito, M; Nozawa, Y; Ohishi, N; Yagi, K1
Arima, T; Ishibashi, K; Ishitsuka, K; Kohara, K; Komorizono, Y; Oketani, M; Tuvdendorj, D1
Grinnell, F; Shere, PA1
Khan, H; Rana, SVS; Verma, Y1
Chen, H; Chen, J; Chen, X; Chen, Z; Huang, Y; Li, D; Su, Z; Wang, H1
Deng, M; Gao, M; Guo, G; Han, J; Huang, H; Huang, J; Huang, X; Jing, J; Kloeber, JA; Liu, S; Lou, Z; Qi, Z; Xu, M; Xu, Z1
Acharya, PB; Kuppusamy Selvam, M; Mukherjee, A; Singh, A1
Chen, J; Gu, J; Guo, J; Hu, X; Li, D; Li, X; Liu, J; Mei, C; Peng, C; Xiao, Y; Zhang, K; Zhang, X; Zhou, B1
Cao, H; Liu, Q; Sun, J; Wu, L; Wu, M1
El-Serag, HB; Olayode, A; Oluyomi, AO; Roy, H; Symanski, E; Thrift, AP1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z1
Chen, L; Liu, S; Wu, B; Yu, J1
Jin, Z; Wu, P; Yan, G; Yang, J; Yi, X; Zhou, M1
Jiang, W; Liu, S; Nurmamat, H; Shen, Z; Wu, B; Wu, J; Yu, Y1
Biondi, A; Costa, C; Costanzo, V; Fago, L; Fenga, C; Ferrante, M; Fuccio Sanzà, G; Ledda, C; Loreto, C; Marconi, A; Matera, S; Palmucci, S; Pomara, C; Rapisarda, V; Zammit, C1
Choiniere, J; Wang, L; Wu, J1
Liu, J; Waalkes, MP1
Chang-Chien, GP; Chou, IC; Lee, H; Wang, LC; Wu, YL1
Lai, R; Li, X; Wang, Y; Yu, RA1
Kim, EY; Kim, HJ; Kim, TH; Park, CS; Park, YS; Shin, JH; Song, HY1
Callegari, E; Elamin, BK; Gramantieri, L; Negrini, M; Sabbioni, S1
Centeno, JA; Gibb, H; Ladich, ER; Longfellow, D; Martinez, L; Mullick, FG; Page, NP; Thompson, C1
Diwan, BA; Liu, J; Waalkes, MP; Ward, JM; Xie, Y1
Carr, BI; Chang, TT; Chen, SC; Chow, NH; Huang, WS; Lin, CH; Lu, SN; Wu, WC1
El-Kadi, AO; Elbekai, RH1
Chiu, HF; Ho, SC; Wang, LY; Wu, TN; Yang, CY1
Yu, MC; Yuan, JM1
Kim, SG; Lee, CH; Park, JW1
Diwan, BA; Ducharme, DM; Grissom, SF; Liu, J; Merrick, BA; Paules, RS; Shen, J; Tennant, R; Tucker, CJ; Waalkes, MP; Xie, Y1
Cheng, ML; LeCluyse, EL; Liu, J; Lu, T; Waalkes, MP; Zhou, YS1
Gebel, TW1
Popper, H1
Cowen, AE; Cowlishaw, JL; Pollard, EJ; Powell, LW1
Hirayoshi, K; Hosokawa, N; Kioka, N; Komano, T; Nagata, K; Ueda, K1
Fujita, H; Kappas, A; Mitani, K; Sassa, S1
Antoniello, L; Cohen, H; Fosman, E; Rodríguez, J; Rondán, M1
Nigam, VN1
Arcos, JC; Mathison, JB; Mouledoux, AM; Tison, MJ1
Grinnell, F; Milam, M; Srere, PA1

Reviews

10 review(s) available for arsenic and Hepatocellular Carcinoma

ArticleYear
Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
    Nanomedicine (London, England), 2022, Volume: 17, Issue:26

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Oxides

2022
Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Medicine, 2018, Volume: 97, Issue:18

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Oxides; Quality of Life; Survival Rate; Treatment Outcome

2018
Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Databases, Bibliographic; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2017
Non-coding RNA therapeutics: Towards a new candidate for arsenic-induced liver disease.
    Chemico-biological interactions, 2023, Sep-01, Volume: 382

    Topics: Arsenic; Biomarkers; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; MicroRNAs; RNA, Long Noncoding; RNA, Untranslated

2023
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016
Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).
    Molecular medicine reports, 2017, Volume: 15, Issue:2

    Topics: Arsenic; Cadmium; Carcinoma, Hepatocellular; Dioxins; Humans; Liver Neoplasms; Nitrosamines; Occupational Exposure; Pesticides; Polychlorinated Biphenyls; Risk Factors

2017
Liver is a target of arsenic carcinogenesis.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 105, Issue:1

    Topics: Animals; Apoptosis; Arsenic; Carcinoma, Hepatocellular; DNA Damage; DNA Methylation; DNA Repair; Estrogens; Humans; Liver; Liver Neoplasms; Mice

2008
MicroRNA response to environmental mutagens in liver.
    Mutation research, 2011, Dec-01, Volume: 717, Issue:1-2

    Topics: Aflatoxin B1; Animals; Arsenic; Benzo(a)pyrene; Carcinoma, Hepatocellular; Environmental Pollutants; Ethanol; Gene Expression Regulation; Hepacivirus; Hepatitis B virus; Humans; Liver; Liver Neoplasms; MicroRNAs; Mutagens; Nicotiana; Poisons; Risk Factors; Rodenticides; Triazines

2011
Does arsenic exposure increase the risk for liver cancer?
    Journal of toxicology and environmental health. Part A, 2004, Oct-08, Volume: 67, Issue:19

    Topics: Arsenic; Arsenic Poisoning; Carcinoma, Hepatocellular; Environmental Exposure; Female; Humans; Liver Neoplasms; Male; Risk; Sex Factors; Taiwan; Water Pollution, Chemical; Water Supply

2004
Environmental factors and risk for hepatocellular carcinoma.
    Gastroenterology, 2004, Volume: 127, Issue:5 Suppl 1

    Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Diabetes Complications; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Obesity; Risk Factors; Smoking

2004

Trials

8 trial(s) available for arsenic and Hepatocellular Carcinoma

ArticleYear
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma.
    Medicine, 2017, Volume: 96, Issue:35

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cytoskeletal Proteins; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides

2017
Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:6

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Combined Modality Therapy; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oxides; Single-Blind Method; Treatment Outcome; Tumor Burden

2015
Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.
    Cancer, 2015, Sep-01, Volume: 121, Issue:17

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Oxides; Proportional Hazards Models; Treatment Outcome

2015
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
    Investigational new drugs, 2010, Volume: 28, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Arsenicals; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Glutathione; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome

2010
[Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Half-Life; Humans; Injections; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Oxides; Quality of Life; Remission Induction; Survival Rate; Vomiting

2011
[The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases].
    Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:12

    Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oxides; Treatment Outcome

2012
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
    Investigational new drugs, 2007, Volume: 25, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Administration Schedule; Fatigue; Female; Humans; Injections, Intravenous; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxides; Survival Analysis; Treatment Outcome

2007
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016

Other Studies

113 other study(ies) available for arsenic and Hepatocellular Carcinoma

ArticleYear
Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
    Biological trace element research, 2023, Volume: 201, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Emodin; Humans; Liver Neoplasms; Oxides; Quercetin; Telomerase

2023
Induction of filamin-C and its involvement in the regulation of cellular senescence and apoptosis in Huh-7 hepatoma cells during arsenic trioxide exposure.
    Biochemical and biophysical research communications, 2023, 04-09, Volume: 651

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cellular Senescence; Filamins; Humans; Liver Neoplasms; Oxides

2023
[Effect of Cell Autophagy on the Apoptosis of Hepatocellular Carcinoma Cells Induced by Arsenic Trioxide].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2017, Volume: 48, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; Microtubule-Associated Proteins

2017
Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.
    Metallomics : integrated biometal science, 2017, 12-01, Volume: 9, Issue:12

    Topics: Apoptosis; Arsenicals; Carcinoma, Hepatocellular; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Mitochondria; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured

2017
γ-Glutamylcysteine synthetase (γ-GCS) as a target for overcoming chemo- and radio-resistance of human hepatocellular carcinoma cells.
    Life sciences, 2018, Apr-01, Volume: 198

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Catalysis; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Glutamate-Cysteine Ligase; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Oxides; Radiation Tolerance; Reactive Oxygen Species

2018
Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells.
    Life sciences, 2018, Jul-15, Volume: 205

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Oxides; Receptors, Notch

2018
Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Cell biochemistry and biophysics, 2014, Volume: 68, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Flavonoids; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Oxides; Reactive Oxygen Species; Transplantation, Heterologous

2014
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.
    Journal of hematology & oncology, 2014, Mar-30, Volume: 7

    Topics: AC133 Antigen; Animals; Antigens, CD; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Glycoproteins; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oxides; Peptides; Random Allocation; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1

2014
Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
    Toxicology letters, 2014, Jun-05, Volume: 227, Issue:2

    Topics: Arsenic Trioxide; Arsenicals; Biomarkers; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Oxides; Signal Transduction

2014
Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:7

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Embolization, Therapeutic; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Oxides; Rats; Rats, Inbred BUF; Twist-Related Protein 1

2014
Humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles, an antibody conjugate with potent and selective anti-hepatocellular carcinoma activity.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2014, Volume: 68, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Immunohistochemistry; Leukocyte Count; Liver Neoplasms; Male; Mice, Nude; Microvessels; Nanoparticles; Oxides; Platelet Count; Single-Chain Antibodies; Tissue Distribution; Vascular Endothelial Growth Factor Receptor-2

2014
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Molecular cancer, 2014, May-31, Volume: 13

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Nuclear Proteins; Oxides; Piperazines; Signal Transduction; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2014
All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
    Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; Oxides; Tretinoin

2014
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Toxicology letters, 2014, Nov-18, Volume: 231, Issue:1

    Topics: 3' Untranslated Regions; Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; MicroRNAs; Neovascularization, Pathologic; Neovascularization, Physiologic; NF-kappa B; Oxides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

2014
Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 143, Issue:1

    Topics: 3' Untranslated Regions; AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplastic Stem Cells; Oxides; Peptides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Xenograft Model Antitumor Assays

2015
[The apoptotic mechanism of hepatocellular carcinoma cell line (HepG2) induced by arsenic trioxide].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014, Volume: 45, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Glutamate-Cysteine Ligase; Glutathione; Hep G2 Cells; Humans; Liver Neoplasms; Oxides; Reactive Oxygen Species

2014
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Proteins; Niacinamide; Oxides; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib

2015
Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Oxides; Proto-Oncogene Proteins c-bcl-2

2015
PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Chemico-biological interactions, 2015, Jan-25, Volume: 226

    Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cyclin B1; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Naphthalimides; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Up-Regulation

2015
[4-amino-1,8-naphthalimide on the Sensitive effect of arsenic trioxide in hepatocellular carcinoma cells].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2015, Volume: 46, Issue:2

    Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Survival; DNA Damage; DNA Repair; Hep G2 Cells; Humans; Liver Neoplasms; Naphthalimides; Oxides; Quinolones

2015
The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    The Journal of toxicological sciences, 2015, Volume: 40, Issue:3

    Topics: 1-Naphthylamine; Acetylcysteine; Antineoplastic Agents; Antioxidants; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Damage; Hep G2 Cells; Humans; Inactivation, Metabolic; Liver Neoplasms; Naphthalimides; NF-kappa B; Oxidative Stress; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Reactive Oxygen Species

2015
Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
    Cancer letters, 2015, Sep-28, Volume: 366, Issue:1

    Topics: Adult; Aged; Aldehyde Dehydrogenase; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins

2015
Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Molecular medicine reports, 2016, Volume: 13, Issue:3

    Topics: Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxides; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; V-Set Domain-Containing T-Cell Activation Inhibitor 1; Vascular Endothelial Growth Factor A

2016
A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.
    Nanoscale, 2016, Feb-21, Volume: 8, Issue:7

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Female; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Mice; Mice, Inbred ICR; Microscopy, Electron, Transmission; Nanoparticles; Oxides; Porosity; Silicon Dioxide; Surface Properties; Transplantation, Heterologous

2016
[Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Sorafenib

2015
[The Experiment Study and Mechanism of Aspirin Enhances Cellular Sensitivity of Hepatocellular Carcinoma Cell Line to Arsenic Trioxide].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2016, Volume: 47, Issue:2

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Heme Oxygenase-1; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxides; Reactive Oxygen Species

2016
Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Oncotarget, 2016, Oct-25, Volume: 7, Issue:43

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; DNA Damage; Drug Synergism; Endoplasmic Reticulum Stress; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Nude; Naphthoquinones; Oxides; Xenograft Model Antitumor Assays

2016
microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Life sciences, 2016, Dec-01, Volume: 166

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice, Nude; MicroRNAs; Oxides

2016
SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
    Oncology reports, 2016, Volume: 36, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Inhibitor of Apoptosis Proteins; Liposomes; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mutation, Missense; Neoplasm Transplantation; Oxides; Reactive Oxygen Species; Repressor Proteins; Survivin

2016
Arsenic trioxide is an immune adjuvant in liver cancer treatment.
    Molecular immunology, 2017, Volume: 81

    Topics: Adjuvants, Immunologic; Animals; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cytokine-Induced Killer Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Mice; Oxides; Real-Time Polymerase Chain Reaction; T-Lymphocytes; Xenograft Model Antitumor Assays

2017
Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS.
    International journal of oncology, 2017, Volume: 50, Issue:2

    Topics: Acidithiobacillus; Antineoplastic Agents; Apoptosis; Arsenicals; Biodegradation, Environmental; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Reactive Oxygen Species; Sulfides

2017
RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
    International journal of pharmaceutics, 2017, Mar-15, Volume: 519, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms; MCF-7 Cells; Mice; Nanoparticles; Oligopeptides; Oxides; Silicon Dioxide

2017
Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 88

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Tumor Microenvironment; Xenograft Model Antitumor Assays

2017
Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:2

    Topics: Androstadienes; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Wortmannin

2009
Possible roles of a tumor suppressor gene PIG11 in hepatocarcinogenesis and As2O3-induced apoptosis in liver cancer cells.
    Journal of gastroenterology, 2009, Volume: 44, Issue:5

    Topics: Adult; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Child; Cycloheximide; Dactinomycin; Down-Regulation; Female; Gene Expression; Gene Knockdown Techniques; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Oxides; Protein Synthesis Inhibitors

2009
Structure-effect relationship in the down-regulation of glutaminase in cultured human cells by phenylarsenic compounds.
    Toxicology, 2009, Apr-28, Volume: 258, Issue:2-3

    Topics: Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Glutaminase; Hepatocytes; Humans; Liver Neoplasms; Molecular Structure; Time Factors

2009
Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2009, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice; NM23 Nucleoside Diphosphate Kinases; Oxides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2009
Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Cancer science, 2010, Volume: 101, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Synergism; Genistein; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Oxides; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2010
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Cancer letters, 2011, Feb-01, Volume: 301, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Synergism; Genistein; Hep G2 Cells; Humans; Liver Neoplasms; Mice; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2011
microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
    Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hep G2 Cells; Humans; Liver Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Oxides; Phosphoprotein Phosphatases; Protein Phosphatase 2C; Reverse Transcriptase Polymerase Chain Reaction; Transfection

2011
Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma.
    Annals of surgical oncology, 2011, Volume: 18, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Liver Neoplasms; Membrane Potential, Mitochondrial; Nitric Oxide; Oxides; Oxygen; Reactive Oxygen Species; Tumor Cells, Cultured

2011
Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
    Cell biology international, 2011, Volume: 35, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Humans; Inhibitor of Apoptosis Proteins; Interferon Inducers; Liver Neoplasms; Mitochondria; Oxides; Poly I-C; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Survivin; Toll-Like Receptor 3

2011
[Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:1

    Topics: Amphibian Venoms; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oxides; Phytotherapy; Xenograft Model Antitumor Assays

2011
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
    Anti-cancer drugs, 2011, Volume: 22, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Growth Processes; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxides; Telomerase; Xenograft Model Antitumor Assays; Zidovudine

2011
Pharmacokinetics of arsenic trioxide (As₂O₃) in Chinese primary hepatocarcinoma patients.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:1

    Topics: Area Under Curve; Arsenic Trioxide; Arsenicals; Asian People; Carcinoma, Hepatocellular; Female; Half-Life; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides

2011
Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    The Biochemical journal, 2011, Sep-01, Volume: 438, Issue:2

    Topics: 3' Untranslated Regions; Antigens, Surface; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; ELAV Proteins; ELAV-Like Protein 1; ErbB Receptors; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Homeodomain Proteins; Humans; Liver Neoplasms; Models, Biological; Oxides; Phosphatidylinositol 3-Kinases; Repressor Proteins; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta

2011
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
    Hematology/oncology and stem cell therapy, 2011, Volume: 4, Issue:2

    Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Capecitabine; Carcinoma, Hepatocellular; Cell Line; Cisplatin; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Glycoproteins; Hep G2 Cells; Humans; Immunohistochemistry; Interferon-alpha; Liver Neoplasms; Oxides; Peptides; Rhodamine 123; Thy-1 Antigens

2011
Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Ceramides; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Microscopy, Fluorescence; Neoplasm Invasiveness; Oxides; Sphingomyelin Phosphodiesterase

2012
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    International journal of oncology, 2012, Volume: 40, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diterpenes, Kaurane; Drug Synergism; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; NF-kappa B; Oxides; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; X-Linked Inhibitor of Apoptosis Protein

2012
Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice.
    Archives of toxicology, 2012, Volume: 86, Issue:6

    Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Animals; Arsenic; Arsenicals; Carcinogens; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Lung Neoplasms; Male; Maternal Exposure; Mice; Neoplasms; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Testicular Neoplasms; Uterine Neoplasms

2012
Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:11

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cyclin B; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Nuclear Proteins; Oxides; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction

2012
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    BMC cancer, 2012, Sep-10, Volume: 12

    Topics: Adult; AMP-Activated Protein Kinases; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Activation; Fluorouracil; Gene Expression Regulation, Enzymologic; Growth Inhibitors; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Thymidylate Synthase; Time Factors

2012
[Inhibitory effect of arsenic trioxide on invasion in human hepatocellular carcinoma SMMC-7721 cells and its mechanism].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2012, Volume: 28, Issue:12

    Topics: Arsenic Trioxide; Arsenicals; Basigin; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Oxides

2012
[Comparison of antitumor efficacy between arsacetyl and arsenic trioxide in vitro].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Fragmentation; Drug Screening Assays, Antitumor; Endothelium, Vascular; Flow Cytometry; G1 Phase; Humans; Inhibitory Concentration 50; Liver Neoplasms; Oxides; Resting Phase, Cell Cycle; Tumor Cells, Cultured

2002
Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinogens; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 CYP1A1; Dioxins; Drug Synergism; Enzyme Induction; Genes, Reporter; Hepatocytes; Humans; Immunoblotting; In Vitro Techniques; Liver Neoplasms; Mitochondrial Proteins; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Oxides; Polycyclic Aromatic Hydrocarbons; Protein Processing, Post-Translational; Reactive Oxygen Species; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Transcription, Genetic; Tumor Cells, Cultured

2003
Synergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.
    World journal of gastroenterology, 2003, Volume: 9, Issue:1

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Survival; Flow Cytometry; Growth Inhibitors; Humans; Liver Neoplasms; Oxides; Tumor Cells, Cultured

2003
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
    Cancer research, 2003, Apr-15, Volume: 63, Issue:8

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Coculture Techniques; Glutathione Peroxidase; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lymphoma; Methylation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured

2003
Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
    Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Female; Liver Neoplasms; Male; Microscopy, Electron; Oxides; Rats; Rats, Wistar; Tumor Cells, Cultured

2003
Antitumor effect of arsenic trioxide in murine xenograft model.
    Cancer science, 2003, Volume: 94, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain; Carcinoma, Hepatocellular; Humans; In Situ Nick-End Labeling; Injections, Intravenous; Kidney; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Spectrometry, X-Ray Emission; Transplantation, Heterologous; Tumor Cells, Cultured

2003
[Application of arsenic trioxide in comprehensive therapy of liver carcinoma].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2003, Volume: 23, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Oxides

2003
Effect of arsenic trioxide on human hepatocarcinoma in nude mice.
    World journal of gastroenterology, 2004, Dec-15, Volume: 10, Issue:24

    Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blood Platelets; Carcinoma, Hepatocellular; Hemoglobins; Humans; Kidney; Leukocytes; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Oxides

2004
[Study on effect of arsenic trioxide on adhesion and invasion of human hepatocarcinoma cells in vitro].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2004, Volume: 24, Issue:10

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Liver Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neoplasm Invasiveness; Oxides

2004
[The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2005, Jan-01, Volume: 43, Issue:1

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Middle Aged; Oxides

2005
Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 87, Issue:1

    Topics: Animals; Arsenic; Arsenicals; Cacodylic Acid; Carcinoma, Hepatocellular; Cell Cycle; Cell Nucleus; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Electroporation; Fibroblasts; Humans; Micronucleus Tests; Organometallic Compounds

2005
Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
    Cancer letters, 2006, May-18, Volume: 236, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Oxides

2006
Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas.
    International journal of cancer, 2006, Apr-01, Volume: 118, Issue:7

    Topics: Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; B7 Antigens; B7-1 Antigen; Carcinoma, Hepatocellular; Combined Modality Therapy; Gene Transfer Techniques; Humans; Immunotherapy; Interferon-gamma; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Receptors, Immunologic; T-Lymphocytes, Cytotoxic

2006
Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro.
    World journal of gastroenterology, 2005, Sep-28, Volume: 11, Issue:36

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Glutathione Transferase; Humans; Lung Neoplasms; Oxides; Tretinoin

2005
The role of glutathione on the cytotoxic effects and cellular uptake of diphenylarsinic acid, a degradation product of chemical warfare agents.
    Archives of toxicology, 2006, Volume: 80, Issue:8

    Topics: Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chemical Warfare Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glutathione; Hepatocytes; Humans; Mass Spectrometry

2006
Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
    Human pathology, 2006, Volume: 37, Issue:3

    Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Neoplasm; Genes, p16; Glutathione S-Transferase pi; Hepatocytes; Humans; Liver Neoplasms; Male; Middle Aged; Oxides; RNA, Messenger; Tumor Suppressor Proteins

2006
Glutathione plays a role in regulating the formation of toxic reactive intermediates from diphenylarsinic acid.
    Toxicology, 2006, Aug-15, Volume: 225, Issue:2-3

    Topics: Arsenic Poisoning; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemical Warfare Agents; Chromatography, High Pressure Liquid; Glutathione; Hepatocytes; Humans; Protein Binding; Spectrometry, Mass, Electrospray Ionization

2006
Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:8

    Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Free Radical Scavengers; Humans; Liver Neoplasms; Oxidative Stress; Oxides; Proto-Oncogene Proteins c-bcl-2

2006
Down-regulation of glutaminase C in human hepatocarcinoma cell by diphenylarsinic acid, a degradation product of chemical warfare agents.
    Toxicology and applied pharmacology, 2007, May-01, Volume: 220, Issue:3

    Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Arsenicals; Arsenites; Cacodylic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Chaperonin Containing TCP-1; Chaperonins; Chemical Warfare Agents; Dose-Response Relationship, Drug; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique; Glutaminase; HeLa Cells; Humans; Immunoblotting; Isoenzymes; Retinal Dehydrogenase; Ribosomal Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors

2007
Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
    Toxicology and applied pharmacology, 2008, Jan-15, Volume: 226, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dithiothreitol; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Environmental Pollutants; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Oxides; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2008
[Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:12

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; COP9 Signalosome Complex; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Oxides; Peptide Hydrolases

2007
Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death.
    Cell research, 2008, Volume: 18, Issue:4

    Topics: Animals; Arsenic Trioxide; Arsenicals; Binding Sites; Carcinoma, Hepatocellular; Caspases; Cell Death; Cell Line, Tumor; Cytochromes c; Dinitrochlorobenzene; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Liver Neoplasms; Mice; Mitochondria; Mitochondrial Swelling; Mutant Proteins; NADP; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Recombinant Proteins; RNA Interference; Thioredoxins

2008
[Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Niacinamide; Oxides; Phenylurea Compounds; Pyridines; Sorafenib

2008
DNA binding activity of the aryl hydrocarbon receptor is sensitive to redox changes in intact cells.
    Archives of biochemistry and biophysics, 1998, Oct-01, Volume: 358, Issue:1

    Topics: Animals; Arsenicals; Biological Transport; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Diamide; Dimercaprol; DNA-Binding Proteins; DNA, Neoplasm; Mercaptoethanol; Mice; Oxidation-Reduction; Receptors, Aryl Hydrocarbon; Sp1 Transcription Factor; Transcription, Genetic; Tumor Cells, Cultured; Xenobiotics

1998
[An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2000, Volume: 8, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; fas Receptor; Genes, bcl-2; Humans; In Situ Nick-End Labeling; Liver Neoplasms; Oxides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; S Phase; Tumor Cells, Cultured

2000
Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase.
    Biochemical and biophysical research communications, 2001, Apr-20, Volume: 282, Issue:5

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Culture Media, Conditioned; Dexamethasone; Dose-Response Relationship, Drug; Drug Antagonism; Glucocorticoids; Insulin; Insulin Antagonists; Insulin-Like Growth Factor Binding Protein 1; Multienzyme Complexes; Oxides; Protein Serine-Threonine Kinases; Rats; Ribonucleotides; Signal Transduction; Tumor Cells, Cultured

2001
Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.
    World journal of gastroenterology, 2001, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Oxides; Tumor Cells, Cultured

2001
Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Biochemical and biophysical research communications, 2002, Mar-08, Volume: 291, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Nucleus; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Kinetics; Liver Neoplasms; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured

2002
Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis.
    Life sciences, 2002, Jun-07, Volume: 71, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Cycle; Cell Division; Enzyme Activation; Humans; Liver Neoplasms; Mitochondria; Oxides; Tumor Cells, Cultured

2002
Inhibition by arsenic trioxide of human hepatoma cell growth.
    Cancer letters, 2002, Sep-26, Volume: 183, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Coloring Agents; Dose-Response Relationship, Drug; Flow Cytometry; Glutathione; Humans; Oxides; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured

2002
Inhibition of cellular adhesiveness by sulfhydryl blocking agents.
    Journal of cellular physiology, 1971, Volume: 78, Issue:1

    Topics: Alkylating Agents; Animals; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line; Cells, Cultured; Culture Media; Culture Techniques; Dithiothreitol; Liver Neoplasms; Mercuribenzoates; Polystyrenes; Rats; Sulfhydryl Reagents; Time Factors

1971
Significance of Inflammation and Apoptosis in Hepatocellular Death in Rat, Co-treated with Arsenic and Fluoride.
    Biological trace element research, 2022, Volume: 200, Issue:7

    Topics: Animals; Apoptosis; Arsenic; Body Weight; Carcinoma, Hepatocellular; Caspase 9; Female; Fluorides; Inflammation; Liver Neoplasms; Oxidative Stress; Rats; Rats, Wistar

2022
Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Journal of nanobiotechnology, 2022, Jan-15, Volume: 20, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Humans; Imidazoles; Liver Neoplasms; Metal-Organic Frameworks; Mice; Nanoparticles; Radiofrequency Ablation; Tissue Distribution

2022
The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
    Oncogene, 2022, Volume: 41, Issue:33

    Topics: Arsenic; Carcinoma, Hepatocellular; Heme Oxygenase-1; Humans; Liver Neoplasms; Oxidative Stress; Ubiquitin-Specific Peptidase 7

2022
Identification of therapeutic miRNAs from the arsenic induced gene expression profile of hepatocellular carcinoma.
    Chemical biology & drug design, 2023, Volume: 101, Issue:5

    Topics: Arsenic; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Transcriptome

2023
Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma.
    ACS applied materials & interfaces, 2023, Feb-08, Volume: 15, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Biomimetics; Carcinoma, Hepatocellular; Cell Line, Tumor; Ferroptosis; Liver Neoplasms; Magnetic Iron Oxide Nanoparticles; Mice

2023
Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study.
    Environmental research, 2024, Jan-01, Volume: 240, Issue:Pt 2

    Topics: Adult; Arsenic; Carcinoma, Hepatocellular; Ethnicity; Female; Humans; Incidence; Liver Neoplasms; Male; Receptors, Antigen, T-Cell; Sex Characteristics; Texas; Young Adult

2024
Combined effects of arsenic and palmitic acid on oxidative stress and lipid metabolism disorder in human hepatoma HepG2 cells.
    The Science of the total environment, 2021, May-15, Volume: 769

    Topics: Arsenic; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Lipid Metabolism; Lipid Metabolism Disorders; Oxidative Stress; Palmitic Acid

2021
Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic; Carcinoma, Hepatocellular; Cell Cycle; Drug Delivery Systems; Drug Synergism; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays

2021
Comparison of cytotoxicity and membrane efflux pump inhibition in HepG2 cells induced by single-walled carbon nanotubes with different length and functional groups.
    Scientific reports, 2019, 05-17, Volume: 9, Issue:1

    Topics: Arsenic; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Fluidity; Nanotubes, Carbon; Oxidative Stress; Reactive Oxygen Species

2019
Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.
    Molecular pharmacology, 2017, Volume: 91, Issue:3

    Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Cell Proliferation; Cyclins; Disease Progression; E2F1 Transcription Factor; Flow Cytometry; Hepatocytes; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Protein Kinases; Sequence Analysis, RNA

2017
Metal interference on luciferase activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in bioassays of recombinant mouse hepatoma cells.
    Journal of hazardous materials, 2009, Jun-15, Volume: 165, Issue:1-3

    Topics: Animals; Arsenic; Cadmium; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromium; Dose-Response Relationship, Drug; Gene Expression Regulation; Lead; Luciferases; Metals; Mice; Polychlorinated Dibenzodioxins; Transfection

2009
[Effect of selenium and arsenic on oxidative stress, DNA oxidative damage and repair in HepG2 cells].
    Wei sheng yan jiu = Journal of hygiene research, 2008, Volume: 37, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Carcinoma, Hepatocellular; Deoxyguanosine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Malondialdehyde; Oxidative Stress; Selenium

2008
Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
    Journal of vascular and interventional radiology : JVIR, 2009, Volume: 20, Issue:10

    Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Embolization, Therapeutic; Emulsions; Hemostatics; Humans; Iodized Oil; Liver; Liver Neoplasms; Rabbits; Treatment Outcome

2009
Pathology related to chronic arsenic exposure.
    Environmental health perspectives, 2002, Volume: 110 Suppl 5

    Topics: Adolescent; Adult; Aged; Arsenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Environmental Exposure; Female; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Skin Diseases; Water Supply

2002
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 77, Issue:2

    Topics: Animals; Arsenic; Carcinogens; Carcinoma, Hepatocellular; Drinking; Female; Gene Expression; Gene Expression Profiling; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Oligonucleotide Array Sequence Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Reverse Transcriptase Polymerase Chain Reaction; Water; Water Pollutants, Chemical

2004
Characteristics of hepatocellular carcinoma in a high arsenicism area in Taiwan: a case-control study.
    Journal of occupational and environmental medicine, 2004, Volume: 46, Issue:5

    Topics: Aged; Arsenic; Carcinoma, Hepatocellular; Case-Control Studies; Female; Humans; Male; Middle Aged; Taiwan; Water Pollutants, Chemical; Water Supply

2004
Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium.
    Toxicology, 2004, Oct-01, Volume: 202, Issue:3

    Topics: Animals; Arsenic; Cadmium; Carcinogens; Carcinoma, Hepatocellular; Chromium; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression Regulation, Neoplastic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Ligands; Mutagens; Receptors, Aryl Hydrocarbon; RNA, Messenger; Tumor Cells, Cultured

2004
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.
    Journal of toxicology and environmental health. Part A, 2004, Volume: 67, Issue:23-24

    Topics: Animals; Antiparkinson Agents; Arsenic; Carcinoma, Hepatocellular; Cell Culture Techniques; Drug Interactions; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Rats; Selegiline; Tumor Cells, Cultured

2004
Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure.
    Environmental health perspectives, 2006, Volume: 114, Issue:3

    Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Pregnancy; Prenatal Exposure Delayed Effects; Toxicogenetics

2006
Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China.
    Toxicological sciences : an official journal of the Society of Toxicology, 2001, Volume: 59, Issue:1

    Topics: Arsenic; Arsenic Poisoning; Biopsy, Needle; Carcinogens, Environmental; Carcinoma, Hepatocellular; China; DNA, Complementary; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Necrosis; Oligonucleotide Array Sequence Analysis; RNA

2001
Unanswered questions in arsenic toxicology.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2001, Volume: 20, Issue:4

    Topics: Antimony; Arsenic; Carcinoma, Hepatocellular; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Environmental Exposure; Humans; Nutrition Disorders; Public Health; Risk Assessment; Selenium; Tumor Cells, Cultured; Water Supply

2001
[Liver tumors caused by environmental factors].
    Der Internist, 1977, Volume: 18, Issue:4

    Topics: Anabolic Agents; Animals; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Environmental Exposure; Environmental Health; Female; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasms, Experimental; Occupational Diseases; Precancerous Conditions; Rodentia; Thorium Dioxide; Vinyl Chloride

1977
Liver disease associated with chronic arsenic ingestion.
    Australian and New Zealand journal of medicine, 1979, Volume: 9, Issue:3

    Topics: Arsenic; Carcinoma, Basal Cell; Carcinoma, Hepatocellular; Humans; Keratosis; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Skin Neoplasms

1979
Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite.
    FEBS letters, 1992, Apr-27, Volume: 301, Issue:3

    Topics: Arsenic; Arsenites; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Carcinoma, Hepatocellular; Chloramphenicol O-Acetyltransferase; Drug Antagonism; Drug Resistance; Gene Expression; Membrane Glycoproteins; Plasmids; Quercetin; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured

1992
Activation of heme oxygenase and heat shock protein 70 genes by stress in human hepatoma cells.
    Biochemical and biophysical research communications, 1990, Feb-14, Volume: 166, Issue:3

    Topics: Arsenic; Arsenites; Cadmium; Cadmium Chloride; Carcinoma, Hepatocellular; Cell Line; Gene Expression Regulation; Heat-Shock Proteins; Heme; Heme Oxygenase (Decyclizing); Hot Temperature; Humans; Iodoacetamide; Kinetics; Liver Neoplasms; Mixed Function Oxygenases; RNA, Messenger; Sodium Compounds; Transcription, Genetic; Tumor Cells, Cultured

1990
[Hepato-splenic hemangiosarcoma: presentation of a clinical case].
    Revista espanola de las enfermedades del aparato digestivo, 1989, Volume: 76, Issue:3

    Topics: Aged; Agricultural Workers' Diseases; Arsenic; Carcinoma, Hepatocellular; Colonic Neoplasms; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Mesentery; Neoplasms, Multiple Primary; Omentum; Peritoneal Neoplasms; Splenic Neoplasms; Uruguay

1989
ATP level and control of glycolysis in Novikoff ascites-hepatoma cells.
    Enzymologia, 1969, Volume: 36, Issue:4

    Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Arsenic; Ascites; Carcinoma, Hepatocellular; Dinitrophenols; Glucose; Glycolysis; Hexosephosphates; Iodoacetates; Lactates; Liver Neoplasms; Neoplasms, Experimental; Rats; Stimulation, Chemical

1969
Effect of feeding amino azo dyes on mitochondrial swelling and contraction. Kinetic evidence for deletion of membrane regulatory sites.
    Cancer research, 1969, Volume: 29, Issue:6

    Topics: Adenosine Triphosphate; Animals; Arsenic; Carcinoma, Hepatocellular; Cell Membrane; Chloromercuribenzoates; Kinetics; Liver Neoplasms; Male; Methods; Mitochondria, Liver; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Phlorhizin; Phosphates; Potassium Chloride; Proteins; Rats; Saponins; Sucrose; Thyroxine; Time Factors

1969
Studies on cell adhesion. II. Adhesion of cells to surfaces of diverse chemical composition and inhibition of adhesion by sulfhydryl binding reagents.
    Archives of biochemistry and biophysics, 1972, Volume: 153, Issue:1

    Topics: Agar; Alloys; Aluminum; Animals; Arsenic; Carcinoma, Hepatocellular; Cell Adhesion; Cell Division; Cell Line; Densitometry; Ethylmaleimide; Glass; Iodoacetates; Kinetics; Liver Neoplasms; Mercuribenzoates; Mercury; Polyethylenes; Polymers; Polytetrafluoroethylene; Rats; Silicones

1972